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Background: Intensive lifestyle interventions in well-controlled settings are effective in lowering the risk of chronic
diseases such as type 2 diabetes (T2DM) and cardiovascular diseases (CVD), but there are still no effective lifestyle
interventions for everyday practice. In the Hoorn Prevention Study we aimed to assess the effectiveness of a
primary care based lifestyle intervention to reduce the estimated risk of developing T2DM and for CVD mortality,
and to motivate changes in lifestyle behaviors.
Methods: The Hoorn Prevention Study is a parallel group randomized controlled trial, implemented in the region
of West-Friesland, the Netherlands. 622 adults with ≥10% estimated risk of T2DM and/or CVD mortality were
randomly assigned and monitored over a period of 12 months. The intervention group (n=314) received a theory-
based lifestyle intervention based on an innovative combination of motivational interviewing and problem solving
treatment, provided by trained practice nurses in 12 general practices. The control group (n=308) received existing
health brochures. Primary outcomes was the estimated diabetes risk according to the formula of the Atherosclerosis
Risk In Communities (ARIC) Study, and the estimated risk for CVD mortality according to the Systematic COronary
Risk Evaluation (SCORE) formula. Secondary outcomes included lifestyle behavior (diet, physical activity and
smoking). The research assistants, the principal investigator and the general practitioners were blinded to group
assignment. Linear and logistic regression analysis was applied to examine the between-group differences in each
outcome measure, adjusted for baseline values.
Results: 536 (86.2%) of the 622 participants (age 43.5 years) completed the 6-month follow-up, and 502 (81.2%)
completed the 12-month follow-up. The mean baseline T2DM risk was 18.9% (SD 8.2) and the mean CVD mortality
risk was 3.8% (SD 3.0). The intervention group participated in a median of 2 sessions. Intention-to-treat analyses
showed no significant differences in outcomes between the two groups at 6 or 12-months follow-up.
Conclusions: The lifestyle intervention was not more effective than health brochures in reducing risk scores for
T2DM and CVD or improving lifestyle behavior in an at-risk population.
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Overweight, smoking, low levels of physical activity and an
unhealthy diet are major risk factors for chronic diseases
such as type 2 diabetes (T2DM) and cardiovascular dis-
eases (CVD) [1-3]. The high prevalence of these risk fac-
tors has become a major public health problem. More and
more public health policy-makers expect health care pro-
viders to identify at-risk groups and to provide effective
interventions to reverse this trend. It has been well
established that intensive lifestyle interventions can lower
the incidence of T2DM in individuals with impaired glu-
cose metabolism. However, the question remains as to
whether the positive results observed in these highly con-
trolled settings can be achieved in primary health care set-
tings [4,5]. A translation of efficacious interventions to ‘real
life’ settings in order to evaluate its effectiveness is not a
realistic option, because both the available resources and
training facilities in primary health care would be exceeded
[6]. Barriers in translating intensive interventions to a ‘real
life’ setting include lengthy diagnostic testing procedures to
identify pre-diabetes, the cost of highly educated personnel
to provide the intervention, the possible cost of incentives
to motivate participants, and offering the intervention in
locations such as single medical centers [7].
So far, randomized controlled trials evaluating the
effectiveness of programs that target lifestyle behavior(s)
to prevent T2DM or CVD in primary health care set-
tings have had various different results, and if they were
effective, the effects were small and unsustainable [8-13].
Nevertheless, a number of non-randomized and small
randomized studies have shown promising results
[14-16]. To further inform the guidance of clinical prac-
tice and health care delivery there is a need for prag-
matic trials in which high risk individuals are taught to
change, independent of research staff. Such trials must
be matching the targeted individuals' preferences, abil-
ities and environmental constraints [17,18].
To address the current gap in the literature we devel-
oped and implemented a lifestyle intervention for the
primary prevention of T2DM and CVD, tailored to the
available resources and infrastructure for national pri-
mary health care services in the Netherlands.
The aim of this study was to investigate the effective-
ness of a theory-based lifestyle intervention on the esti-
mated risk of developing T2DM and CVD mortality in
adults at risk, compared to providing written informa-
tion only. A further aim was to assess the effects of the
intervention on actual lifestyle behavior (physical activ-
ity, dietary behavior and smoking).
Methods
Study design and participants
The methods and theory underlying the Hoorn Preven-
tion Study, a parallel randomized controlled trial, havebeen reported in detail elsewhere [19]. Between December
2007 and April, 2008, a total of 8,193 men and women,
30–50 years of age, were sent an invitation letter asking
them to participate in a selective screening procedure.
The choice for the age group of 30–50 years was moti-
vated by estimates of Dutch diabetes incidence rates based
on the number of newly diagnosed patients by the general
practitioner (GP) in five GP records [20]. Those estimates
clearly mark the age-period in which incidence-rates start
to rise (i.e. from 30 years onwards). The target group was
approached after the identification of date of birth and
absence of diabetes or known CVD from the computer-
ized databases of the participating general practices
(n=12). All invited individuals were living in various muni-
cipalities in the semi-rural region of West-Friesland in the
Netherlands. The invitation included a tape measure for
the measurement of waist circumference according to
detailed instructions. Of the 3,587 respondents (43.8%),
2,401 responded positively, 921 of whom were eligible
with regard to the pre-set cut-off score of the self-
administered waist-circumference (≥101 cm for men
and ≥87 cm for women). The cut-off scores were set 1
cm under the standard obesity cut-off point in order to
account for a slight imprecision that may occur during
self-measurement. Of these eligible respondents, 772
visited the Diabetes Research Center for baseline mea-
surements, gave written informed consent, and partici-
pated in the trial (Figure 1).
T2DM and CVD risk scores were estimated according
to the formulae described in the diabetes risk formula of
the Atherosclerosis Risk In Communities (ARIC) Study
[21] and the Systematic COronary Risk Evaluation
(SCORE) project, respectively [22]. For both scores, and
for each participant, age was extrapolated to 60 years to
address the problem of a high relative but low absolute
risk in younger persons. This made it possible to identify
a potentially high risk at the age of 60 [22]. All respon-
dents with at least a 10.0% T2DM risk and/or CVD mor-
tality risk and no known prevalent T2DM or CVD were
randomly assigned to either the intervention group or
the control group. Before randomization, we excluded
150 individuals, 140 of whom had a less than 10.0% risk,
and 10 who had undiagnosed T2DM (Figure 1).
The study protocol was approved by the Medical Ethics
Committee of the VU University Medical Center in
Amsterdam, and all participants gave written informed
consent.
Randomization
A randomization schedule was drawn up with a comput-
erized random number generator. If more than one
member of the same family participated, consecutive
members of that family were randomized to the same
group as the first member, to avoid contamination. To
314 allocated to 
intervention group
308 allocated to 
control group
Follow-up 2 
(12 months)
n=253
Follow-up 2 
(12 months)
n=249
Follow-up 1 
(6 months)
n=269
Follow-up 1 
(6 months)
n=267
Loss to follow-up 
(n=47)
38 unable to attend
8 withdrew consent
1 became pregnant
Loss to follow-up 
(n=18)
9 unable to attend
4 withdrew consent
1 unable to contact
4 had diagnosed 
T2DM at follow-up 1
Loss to follow-up 
(n=16)
8 unable to attend
3 withdrew consent
3 unable to contact
1 became pregnant
1 died of CVD
Loss to follow-up 
(n=39)
29 unable to attend
5 withdrew consent
3 became pregnant
2 unable to contact
622 high risk according to ARIC and SCORE, 
randomly assigned
8,193 adults invited, aged 30-50 years
3,587 responded (44%)
772 eligible according to self-reported waist 
circumference and attended measurement visit
140 low risk
10 diagnosed T2DM
4,606 did not 
respond (56%)
1,335 refused
1,480 not eligible
Figure 1 Flow chart of the Hoorn Prevention Study.
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pendent administrative assistant from the Diabetes
Research Center, who had no information at all about
the participants, performed the randomization. This was
achieved by instructing the participants not to commu-
nicate about the intervention with their GP or the med-
ical assistants.
Intervention
The lifestyle intervention was based on the theory of
planned behavior (TPB) [23] and the theory of self-
regulation [24]. The intervention further built on the
approach used in a study carried out by Welschen et al.,
who used similar intervention elements to change the
lifestyle behavior of T2DM patients in order to decrease
their CVD risk [25]. The intervention was provided by
specifically trained practice nurses in the participating
general practices. In six face-to-face 30-minute counsel-
ing sessions, followed by 3-monthly telephone sessions,
motivational interviewing [26] (MI) and problem solving
treatment [27] (PST) were used. The aim of MI was tostrengthen the attitude and intention to change according
to the TPB. An important method to achieve this was the
focus on a discrepancy between the personal goals of the
participants and their actual situation, as described in the
theory of self-regulation. PST was used to support partici-
pants in finding solutions to overcome this discrepancy,
to strengthen their perceived control, and to provide
tools to overcome barriers that hinder changes in life-
style behavior [27].
All practice nurses in the Hoorn Prevention Study re-
ceived 18 hours of specific training from experienced
psychologists prior to the intervention (12 hours of MI
and 6 hours of PST). During the course of the study and
the counseling sessions the practice nurses used a treat-
ment manual developed by the project leader and the
psychologists who provided the training. Practical
coaching was provided halfway through the sessions,
and consisted of one hour of individual coaching with
feedback. A random selection of sessions per practice
nurse, taped on a digital voice recorder, was used during
the coaching. A peer supervision meeting was also
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uniformity of the counseling style among the practice
nurses.
Control group
Participants in the control group received existing bro-
chures containing health guidelines regarding physical
activity and a healthy diet, obtained from the Dutch
Heart Foundation. Smokers received an additional bro-
chure on how to stop smoking from the Dutch Anti-
Smoking Foundation (STIVORO). Control participants
did not receive further contact or counseling.
Outcome measures
The primary outcome measures were the estimated risk
of developing T2DM and the estimated risk of CVD
mortality. The 9-year risk of developing T2DM was esti-
mated with the risk formula derived from data from the
ARIC Study [21], based on ethnicity, parental history of
diabetes, systolic blood pressure, waist circumference,
and height. The 10-year risk of CVD mortality was esti-
mated with the formula developed by the SCORE pro-
ject [22], which includes sex, smoking status, total
cholesterol, and systolic blood pressure.
Secondary outcome measures included:
 self-reported physical activity expressed in terms of
i) metabolic equivalent of task (MET)- minutes per
day light, moderate and vigorous activity (for
classifying physical activity by rate of energy
expenditure, i.e., by intensity) [28], and ii) number
and proportion of participants who met the national
recommendations for physical activity (≥30 minutes
moderate-intensity physical activity such as brisk
walking, on at least five days of the week) [29].
Physical activity was measured with a validated
questionnaire [30].
 fruit intake (pieces per day, and number and
proportion of participants who met the national
recommendation of at least 2 pieces of fruit per day)
and vegetable intake (grams per day, and number
and proportion of participants who met the national
recommendation of at least 200 grams of vegetable
consumption per day). This was assessed according
to an extended and modified version of the 8-item
Food Frequency Questionnaire [31].
 smoking behavior (smoking every day/occasionally/
never smoked), assessed with validated questions
recommended by the World Health Organization
(WHO) for the assessment of smoking status [32].
Height was measured to the nearest 0.1 cm without
shoes using a wall-fixed stadiometer. Weight was mea-
sured to the nearest 0.5 kg, wearing light cloths and noshoes. The standard scales that were used (SECA;
London, UK) were calibrated yearly. Waist circumfer-
ence was measured midway between the lowest rib mar-
gin and the iliac crest. Two measurements to the nearest
0.5 cm were recorded; if the difference between the mea-
surements was greater than 1 cm, a third measurement
was made and the mean of the two closest measure-
ments was calculated. Systolic and diastolic blood pres-
sure were measured after 10 minutes of rest, in a seated
position, with a Colin Press BP 8800p Non-Invasive
Blood Pressure Monitor (Colin Medical Technology
Corporation, USA). Fasting plasma glucose was mea-
sured according to the enzymatic reference method with
hexokinase, HbA1c determination was based on the tur-
bidimetric inhibition immunoassay for haemolysed whole
blood, and total and HDL cholesterol and triglycerides
were measured with the enzymatic colorimetric method.
All laboratory tests were performed using the Cobas
Integra system (Roche diagnostics, Basel, Switzerland).
Data collection was done by medical assistants, who were
unaware of the groups to which the participants were
assigned.
Sample size calculation
For the sample size calculation we used data from a
Dutch working population of overweight people (body
mass index ≥25), in which the standard deviation (SD)
of the ARIC score was 8.11 [33]. For a two-sided detec-
tion of a 5.0% between-group difference in ARIC risk
score (i.e. representing a difference in waist circumfer-
ence of 1.5 cm or a difference in systolic blood pressure
of 4 mmHg), with an alpha of 0.05 and a power of 90.0%
in the present study, 120 participants per group were
needed. However, in order to perform stratified analyses,
and to take loss to follow-up into account, more partici-
pants were needed (i.e. 300 per group).
Data-entry
In order to ensure a high level of data accuracy, 10.0% of
the manually entered data was entered twice, and each
second entry was checked against the first. A maximum
discrepancy level of 1.5% was accepted.
Statistical methods
Descriptive statistics (means (SD), or median and inter-
quartile ranges, as appropriate) were used to describe
the study sample with regard to demographics, physical
characteristics and baseline laboratory values. Linear and
logistic regression analysis was applied to examine the
between-group differences in each outcome measure,
adjusted for baseline values.
We examined effect modification by individual-level
factors, including sex, age, level of education, and T2DM
and CVD risk at baseline. Stratified analyses were
Table 1 Baseline characteristics of randomized
participants in the Hoorn Prevention Study
Control group
(n=308) No. (%)
Intervention group
(n=314) No. (%)
Sex
Female 185 (60.1) 178 (56.7)
Age (yrs), mean (SD) 43.4 (5.5) 43.6 (5.1)
Level of education
≤Primary 103 (33.6) 101 (32.5)
Secondary 145 (47.1) 141 (44.9)
College, university 59 (19.2) 69 (22.0)
Family history of
diabetes
77 (25.0) 94 (29.9)
Anthropometrics,
mean (SD)
Body weight (kg) 90.7 (15.4) 90.2 (15.5)
Waist
circumference (cm)
96.7 (9.7) 96.7 (9.8)
Blood pressure
Systolic (mmHg) 129.3 (13.3) 128.7 (13.2)
Diastolic (mmHg) 73.8 (9.0) 73.0 (9.9)
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was considered to be significant (p<0.1 in this case). All
primary analyses were performed according to the
intention-to-treat principle: participants were analyzed in
the groups to which they were originally randomly
assigned, regardless of whether or not they actually re-
ceived the intervention. Only participants for whom data
were available were included in the analyses. In the ana-
lyses of smoking behavior we only included data of those
who reported being a smoker at baseline. Participants with
a fasting glucose >7.0 mmol/L (confirmed with a second
fasting blood sample) were referred to their GP and then
excluded from consecutive measurements because of the
anticipated extra medical attention they might receive.
Women who became pregnant during follow-up were also
excluded because of potential bias in weight and waist
circumference measurements. A per-protocol analysis
included participants in the intervention group who
attended at least 4 counseling sessions. All analyses were
performed in SPSS 15.0 (SPSS Inc., Chicago, IL, USA).
Results
Figure 1 presents the trial’s flow chart. 622 participants
were randomly assigned to receive either the lifestyle
intervention (n=314) or health brochures only (n=308).
After 6 months, 536 participants (86.2%) attended the first
follow-up measurement, 533 (85.7%) of whom provided
complete data and could be included in the analysis. 502
participants (80.7%) attended the second follow-up meas-
urement. A drop-out analysis showed no significant differ-
ences in baseline values of primary outcome measures
between participants who completed the study and those
who dropped out (T-test ARIC p=0.10 (95% CI −3.63 –
0.33); SCORE p=0.99 (95% CI −0.60 – 0.59)).
The baseline characteristics of the participants in the
two groups were similar (Table 1). The mean age at
baseline was 43.5 years (SD 5.3) and 363 participants
were female (58.4%). Of 22 participants from the control
group and 27 from the intervention group we also in-
cluded the partner, who we assigned to the same group
as the first-included. At baseline, the mean estimated 9-
year risk of developing T2DM was 18.9% (SD 8.2) and
the mean estimated 10-year CVD mortality risk was
3.8% (SD 3.0). Participants in the intervention group re-
ceived a median of 2 (interquartile range 1–3) face-to
-face counseling sessions and a median of 2.3 (interquar-
tile range 1–3) sessions by phone. The baseline and
follow-up values and the differences between groups in
risk scores and lifestyle behavior are shown in Table 2.
T2DM and CVD risk scores
There were no significant between-group differences in
either of the estimated risk scores between the interven-
tion and the control group at either follow-up (Table 2).Lifestyle behavior
An increase in fruit intake of 0.2 pieces of fruit per day
in the control group was found to be significantly differ-
ent after 6 months, but not after 12 months (Table 2).
We found no significant difference between the groups
with regard to changes in physical activity, vegetable in-
take or smoking behavior over the 6 and 12 month
follow-up period.
Secondary analyses (per protocol, sub-group)
Per protocol analyses (n=360) did not affect the findings
described above. Stratified analyses revealed that partici-
pants with a lower level of education in the control
group were responsible for the increase in fruit intake.
In this sub-group analysis the control group (n=308)
consumed, on average, a fourth of a piece of fruit per
day more than the intervention group (n=53) after 6 and
12 months. Stratified analyses of groups separated by the
mean baseline ARIC or mean SCORE risk showed no
change in the results.
Discussion
In the current study we evaluated the effectiveness of an
innovative, theory-based lifestyle intervention carried
out in a primary health care setting. To our knowledge,
we are the first to report on the effects of a lifestyle
intervention to reduce the estimated risk of developing
T2DM and CVD mortality. The cognitive behavior pro-
gram was provided in the participants’ own general prac-
tice, by practice nurses instead of researchers in the
study. At the same time, we were able to monitor the
Table 2 Baseline and follow-up values and group differences in risk scores and lifestyle behavior (95% CI), adjusted for baseline
Control group Intervention group Group differences
Baseline Follow-up 1
(6 months)
Follow-up 2
(12 months)
Baseline Follow-up 1
(6 months)
Follow-up 2
(12 months)
β of between group
difference Follow-up 1
β of between group
difference Follow-up 2
Risk scores
ARIC 18.8 (8.5) 18.0 (7.6) 17.8 (9.2) 19.0 (7.8) 18.8 (8.5) 18.5 (8.3) 0.4 (−0.3 to 1.0) 0.3 (−0.6 to 1.2)
SCORE 3.8 (2.9) 3.7 (3.0) 3.7 (4.6) 4.0 (3.0) 4.0 (3.0) 4.0 (3.0) 0.0 (−0.3 to 0.2) −0.2 (−0.7 to 0.4)
Physical activity
light activitiesa 270
(150;371)
296
(150;399)
261
(137;364)
283 (163;392) 274
(171;393)
266
(171;378)
−13.3 (−36.6 to 10.1) 7.2 (−14.5 to 28.8)
moderate activitiesa 47 (19;120) 47 (19;121) 56 (26;126) 56 (19;150) 47 (21;120) 52 (21;138) −9.5 (−22.3 to 3.2) −9.4 (−22.0 to 3.2)
vigorous activitiesa 0 (0;17) 6 (0;17) 0 (0;17) 0 (0;17) 0 (0;17) 0 (0;17) −0.8 (−3.3 to 1.8) −0.1 (−3.3 to 3.1)
meeting recommendations n (%)b 184 (59.7) 167 (54.2) 160 (51.9) 201 (64.0) 161 (51.3) 162 (51.6) OR 0.7 (0.5 to 1.1) OR 0.9 (0.6 to 1.4)
Dietary behaviors
pieces of fruit per day 1.1 (0.8) 1.3 (1.0) 1.2 (0.9) 1.1 (0.9) 1.1 (0.9) 1.1 (0.9) −0.2 (−0.3 to 0.0) −0.1 (−0.2 to 0.0)
meeting recommendations fruit
intake n (%)c
67 (21.8) 70 (22.7) 68 (22.1) 63 (20.1) 57 (18.2) 58 (18.5) OR 1.6 (0.9 to 2.6) OR 1.4 (0.9 to 2.4)
vegetable intake (grams per day) 150 (70.4) 151 (68.5) 157 (89.9) 148 (69.5) 161 (126.6) 156 (74.6) 9.2 (−7.3 to 25.7) −0.4 (−12.7 to 11.9)
meeting recommendations veg.
intake n (%)d
63 (20.5) 57 (18.5) 56 (18.2) 72 (22.9) 55 (17.5) 62 (19.7) OR 1.1 (0.7 to 1.7) OR 0.9 (0.6 to 1.5)
Smoking behavior
smokers n (%) 54 (17.6) 46 (17.2) 43 (17.0) 74 (23.9) 53 (20.0) 46 (18.3) OR 0.5 (0.2 to 1.9) OR 1.1 (0.4 to 3.1)
Data are mean (standard deviation) unless otherwise specified. CI= confidence interval.
ARIC= Atherosclerosis Risk In Communities formula based on: ethnicity (black yes/no), parental history of diabetes, systolic blood pressure, waist circumference and height.
SCORE= formula developed by the Systematic COronary Risk Evaluation project based on sex, smoking status (smoking yes/no), total cholesterol and systolic blood pressure.
a Based on the Short QUestionnaire to ASsess Health enhancing physical activity (SQUASH). Values are median (Q1;Q3) Metabolic Equivalent of Task (MET)- minutes per day, representing the time engaged in specified
physical activities multiplied by the metabolic equivalent value of each activity. Light activities are rated as 2·0 to < 4.0 METs, moderate activities are rated as ≥ 4.0 to < 6·5 METs, vigorous activities are rated as ≥
6.5 METs.
b Meeting national recommendations on physical activity (≥30 minutes moderate-intensity physical activity such as brisk walking, on at least five days of the week).
c Meeting national recommendations on fruit intake (at least 2 pieces a day).
d Meeting national recommendations on vegetable intake (at least 200 grams a day).
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for the nurse practitioners and feedback on the counsel-
ing sessions by means of tape recordings. In contrast to
the procedure in former lifestyle interventions [4,5], the
participants in our study were encouraged to find solu-
tions instead of being told how to change their behavior,
and they were also taught how to implement these solu-
tions into their life. However, our findings show that the
lifestyle intervention was not more effective than the
provision of health brochures. Implementing lifestyle in-
terventions in everyday practice poses challenging issues
that require further investigation. A special focus in this
regard may be the controllability of the dose of interven-
tion in real-life settings, as this will probably be lower as
compared to highly controlled settings. In addition, the
role of participants’ social and physical environment may
be of greater importance [34].
Earlier research in controlled settings has demon-
strated that, separately, MI and PST are more effective
than attention alone [35,36], and there is evidence to
support the efficacy of MI in a number of programs pro-
moting change in lifestyle behavior [36]. Although it has
been convincingly demonstrated that T2DM can be
delayed or prevented in high risk individuals, it is still a
considerable challenge to provide evidence-based life-
style programs for high risk populations in ‘real life’
settings. Few earlier randomized trials evaluated the
effectiveness of diabetes prevention. These studies were,
in line with our findings, not able to reproduce the very
positive outcomes of previous efficacy trials [13,14].
Most diabetes prevention studies that were carried out
in primary care had insufficient power, used single-
group designs, and/or had high rates of attrition, and
should therefore be interpreted with caution [37,38]. In
the Hoorn Prevention Study we had sufficient power,
randomization was performed at individual level, and
relatively few participants were lost to follow-up. Other
strengths include an appropriate design, choice of staff,
staff training, adequate sample size and the choice for
simple outcome measures. In addition, the participants
did not receive financial incentives, and were recruited
from the general population. Whereas the latter two
arguments may be considered as strengths of the present
study, they may also be associated with the lack of
effectiveness of the intervention.
The findings of our process-evaluation indicate that
the recruitment strategy was adequate and resulted in a
reasonably high reach of the target population [39].
Practice nurses were competent and confident to pro-
vide MI and PST, and participant satisfaction was high.
Nevertheless, the amount of attended sessions was low,
and almost no effects on determinants of behavioral
change were seen [39]. The rather low attendance rate
may have contributed to the absence of an interventioneffect, since a median number of 2 counseling sessions
were attended. On the other hand, after per protocol
analyses (which only included participants who had
attended at least 4 counseling sessions) no change in the
results were seen. Six or less face-to-face sessions as we
provided may not have been enough to induce a sustain-
able lifestyle behavioral change, given that previous effi-
cacious lifestyle interventions provided at least 12
sessions [40-42]. However, since the participants in our
effectiveness study were not even motivated enough to
attend 6 sessions, it is unlikely that they would be willing
to attend more. It must also be mentioned that partici-
pants in our study were, on average, younger, and had a
lower absolute risk of developing T2DM than those en-
rolled in previous effectiveness studies on lifestyle inter-
ventions. With regard to the external validity we like to
point out that the study sample was not culturally di-
verse. Although our population (predominantly from a
Western European culture) was representative for the
study region in the Netherlands, this may affect the
generalizability of findings.
Efforts were made to reduce barriers for participation
to a minimum, as non-respondents are a potential threat
to the external validity of the results [43]. We chose to
approach potential participants via correspondence at
multiple moments, as described by Dillman et al. [44].
Other efforts to reduce non-participation included the
choice to provide the intervention in general practices
(which are near to the homes of the participants), as well
as to minimize the burden of the measurements by using
short questionnaires, and to refrain from using unpleas-
ant measurement methods such as 2-hour oral glucose
tolerance tests.
After 6 and 12 months the lifestyle intervention was
not more effective than the provision of health bro-
chures in improving estimated risk scores for T2DM
and CVD or lifestyle behavior in an at-risk population.
Hence we conclude that the provision of this primary
prevention approach was not effective in a Dutch ‘real
life’ primary care setting.Abbreviations
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